U.S. flag

An official website of the United States government

GTR Home > Tests > Heterotopia, periventricular, 300049, X-linked dominant (Nodular neuronal heterotopia) (MLPA)

Indication

This is a clinical test intended for Help: Diagnosis

Clinical summary

Help

Imported from GeneReviews

FLNA deficiency is associated with a phenotypic spectrum that includes FLNA-related periventricular nodular heterotopia (Huttenlocher syndrome), congenital heart disease (patent ductus arteriosus, atrial and ventricular septal defects), valvular dystrophy, dilation and rupture of the thoracic aortic, pulmonary disease (pulmonary hypertension, alveolar hypoplasia, emphysema, asthma, chronic bronchitis), gastrointestinal dysmotility and obstruction, joint hypermobility, and macrothrombocytopenia.

Clinical features

Help

Imported from Human Phenotype Ontology (HPO)

  • Abnormality of the coagulation cascade
  • Patent ductus arteriosus
  • Intellectual disability, mild
  • Seizure
  • Strabismus
  • Stroke
  • Syndactyly
  • Bicuspid aortic valve
  • Recurrent infections
  • Cerebellar hypoplasia
  • Gray matter heterotopia
  • Bone marrow maturation arrest
  • Hypoplasia of the corpus callosum
  • Abnormality of neuronal migration
  • Short finger
  • Cerebral hemorrhage
  • Clinodactyly
  • Thin corpus callosum
Show all

Conditions tested

Target population

Help

Heterotopia, periventricular, 300049, X-linked dominant (diagnosis/ clinical suspition/ etiology investigation/ classification)

Citations

Not provided

Clinical validity

Help

Not provided

Clinical utility

Help

Not provided

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.